• LAST PRICE
    19.1200
  • TODAY'S CHANGE (%)
    Trending Down-0.4100 (-2.0993%)
  • Bid / Lots
    19.1200/ 1
  • Ask / Lots
    19.1500/ 2
  • Open / Previous Close
    19.1900 / 19.5300
  • Day Range
    Low 18.9950
    High 19.4200
  • 52 Week Range
    Low 18.9950
    High 41.0600
  • Volume
    850,873
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 19.53
TimeVolumeGH
09:32 ET2496419.42
09:33 ET655019.2373
09:35 ET1034119.3
09:37 ET573019.175
09:39 ET602419.0601
09:42 ET90619.21
09:44 ET200019.255
09:46 ET211219.29
09:48 ET616919.32
09:50 ET271919.41
09:51 ET281019.33
09:53 ET628919.29
09:55 ET336819.245
09:57 ET201619.33
10:00 ET157819.335
10:02 ET361419.24
10:04 ET552319.185
10:06 ET450719.1
10:08 ET366819.245
10:09 ET215719.24
10:11 ET191619.17
10:13 ET333119.255
10:15 ET517519.1663
10:18 ET766319.23
10:20 ET340919.12
10:22 ET611419.14
10:24 ET478719.225
10:26 ET300719.17
10:27 ET596119.21
10:29 ET218519.1707
10:31 ET154919.18
10:33 ET591619.21
10:36 ET150019.19
10:38 ET282819.11
10:40 ET458919.14
10:42 ET734219.09
10:44 ET269219.13
10:45 ET92719.11
10:47 ET1028019.052
10:49 ET336619.07
10:51 ET786019.14
10:54 ET259119.135
10:56 ET110019.12
10:58 ET190019.12
11:00 ET50019.13
11:02 ET234119.12
11:03 ET332519.0927
11:05 ET640819.11
11:07 ET478219.14
11:09 ET1384319.08
11:12 ET555819.065
11:14 ET1446419.06
11:16 ET4084219.025
11:18 ET500019.1
11:20 ET1496219.035
11:21 ET285519.1475
11:23 ET455219.125
11:25 ET196219.1493
11:27 ET60019.1275
11:30 ET221419.07
11:32 ET895019.075
11:34 ET60019.09
11:36 ET143719.075
11:38 ET214219.12
11:39 ET2191119.04
11:41 ET296919.04
11:43 ET6535819.075
11:45 ET478419.15
11:48 ET536519.19
11:50 ET2101019.245
11:52 ET442319.17
11:54 ET664119.2717
11:56 ET416419.3
11:57 ET100019.3
11:59 ET272719.265
12:01 ET90019.25
12:03 ET184619.21
12:06 ET419519.19
12:08 ET226319.19
12:10 ET219419.2
12:12 ET45019.1872
12:14 ET176619.18
12:15 ET343419.215
12:17 ET285519.17
12:19 ET90019.15
12:21 ET150019.12
12:24 ET233219.09
12:26 ET250019.09
12:28 ET225019.14
12:30 ET489119.15
12:32 ET409419.15
12:33 ET353619.13
12:35 ET325719.16
12:37 ET136919.135
12:39 ET471719.08
12:42 ET140019.1
12:44 ET125019.15
12:46 ET89019.12
12:48 ET57919.11
12:50 ET1480019.125
12:51 ET278319.07
12:53 ET224119.095
12:55 ET273319.11
12:57 ET428819.095
01:00 ET170919.09
01:02 ET280819.07
01:04 ET906019.04
01:06 ET869819.01
01:08 ET496419.01
01:09 ET175219.01
01:11 ET150019.022
01:13 ET110019.03
01:15 ET1015919.01
01:18 ET261219.03
01:20 ET742419.085
01:22 ET175819.14
01:24 ET243919.11
01:26 ET2491919.1
01:27 ET187319.115
01:29 ET592219.1425
01:31 ET200019.145
01:33 ET256619.105
01:36 ET187019.115
01:38 ET473519.1163
01:40 ET60019.12
01:42 ET79219.12
01:44 ET738319.08
01:45 ET820019.12
01:47 ET498019.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGH
Guardant Health Inc
2.4B
-4.5x
---
United StatesIRWD
Ironwood Pharmaceuticals Inc
2.4B
-2.3x
---
United StatesPTCT
PTC Therapeutics Inc
2.1B
-3.2x
---
United StatesDNA
Ginkgo Bioworks Holdings Inc
3.1B
-3.4x
---
United StatesGLPG
Galapagos NV
2.4B
-552.1x
---
United StatesGMAB
Genmab A/S
19.1B
28.9x
+22.71%
As of 2024-02-28

Company Information

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer globally through the use of its proprietary tests, vast data sets and advanced analytics. The Company has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also has developed Guardant360 TissueNext tissue test for advanced-stage cancer, Guardant Reveal blood test to detect residual and recurring disease in early-stage cancer patients, and Guardant360 Response blood test to predict patient response to immunotherapy or targeted therapy eight weeks earlier than current standard-of-care imaging. The Company’s GuardantINFORM platform is used to help biopharmaceutical companies accelerate precision oncology drug development through the use of this in-silico research platform to unlock further insights into tumor evolution and treatment resistance across various biomarker-driven cancers.

Contact Information

Headquarters
3100 Hanover StreetPALO ALTO, CA, United States 94304
Phone
650-290-7575
Fax
302-531-3150

Executives

Chairman of the Board, Co-Chief Executive Officer
Helmy Eltoukhy
Co-Chief Executive Officer, Director
Amirali Talasaz
Chief Financial Officer
Michael Bell
Chief People Officer
Terilyn Monroe
Chief Information Officer
Kumud Kalia

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.4B
Revenue (TTM)
$563.9M
Shares Outstanding
121.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-4.28
Book Value
$1.30
P/E Ratio
-4.5x
Price/Sales (TTM)
4.2
Price/Cash Flow (TTM)
---
Operating Margin
-106.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.